{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:41:36Z","timestamp":1793882496214,"version":"4.7.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Victoria University Collaborative Research Grant Scheme","award":["VU CRGS 13-16"],"award-info":[{"award-number":["VU CRGS 13-16"]}]},{"name":"Victoria University Collaborative Research Grant Scheme","award":["VU CRGS 13-16"],"award-info":[{"award-number":["VU CRGS 13-16"]}]},{"name":"Victoria University Collaborative Research Grant Scheme","award":["VU CRGS 13-16"],"award-info":[{"award-number":["VU CRGS 13-16"]}]},{"name":"Victoria University Collaborative Research Grant Scheme","award":["VU CRGS 13-16"],"award-info":[{"award-number":["VU CRGS 13-16"]}]},{"name":"Crohn\u2019s & Colitis Foundation Senior Research Award","award":["903433"],"award-info":[{"award-number":["903433"]}]},{"name":"Crohn\u2019s & Colitis Foundation Senior Research Award","award":["903433"],"award-info":[{"award-number":["903433"]}]},{"name":"Australian National Health and Medical Research Council","award":["GNT1158952"],"award-info":[{"award-number":["GNT1158952"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Current treatments for inflammatory bowel disease (IBD) are often inadequate due to limited efficacy and toxicity, leading to surgical resection in refractory cases. IBD\u2019s broad and complex pathogenesis involving the immune system, enteric nervous system, microbiome, and oxidative stress requires more effective therapeutic strategies. In this study, we investigated the therapeutic potential of bone marrow-derived mesenchymal stem cell (BM-MSC) treatments in spontaneous chronic colitis using the <jats:italic>Winnie<\/jats:italic> mouse model which closely replicates the presentation and inflammatory profile of ulcerative colitis. The 14-day BM-MSC treatment regimen reduced the severity of colitis, leading to the attenuation of diarrheal symptoms and recovery in body mass. Morphological and histological abnormalities in the colon were also alleviated. Transcriptomic analysis demonstrated that BM-MSC treatment led to alterations in gene expression profiles primarily downregulating genes related to inflammation, including pro-inflammatory cytokines, chemokines and other biomarkers of inflammation. Further evaluation of immune cell populations using immunohistochemistry revealed a reduction in leukocyte infiltration upon BM-MSC treatment. Notably, enteric neuronal gene signatures were the most impacted by BM-MSC treatment, which correlated with the restoration of neuronal density in the myenteric ganglia. Moreover, BM-MSCs exhibited neuroprotective effects against oxidative stress-induced neuronal loss through antioxidant mechanisms, including the reduction of mitochondrial-derived superoxide and attenuation of oxidative stress-induced HMGB1 translocation, potentially relying on MSC-derived SOD1. These findings suggest that BM-MSCs hold promise as a therapeutic intervention to mitigate chronic colitis by exerting anti-inflammatory effects and protecting the enteric nervous system from oxidative stress-induced damage.<\/jats:p>","DOI":"10.1038\/s41598-024-57070-6","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T05:09:06Z","timestamp":1710911346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Bone marrow-derived mesenchymal stem cells mitigate chronic colitis and enteric neuropathy via anti-inflammatory and anti-oxidative mechanisms"],"prefix":"10.1038","volume":"14","author":[{"given":"Rhian","family":"Stavely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainsley M.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiannon T.","family":"Filippone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Stojanovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaraman","family":"Eri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasso","family":"Apostolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Sakkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulmira","family":"Nurgali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"issue":"6","key":"57070_CR1","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","volume":"140","author":"J Cosnes","year":"2011","unstructured":"Cosnes, J. et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140(6), 1785-1794.e1784 (2011).","journal-title":"Gastroenterology"},{"issue":"1","key":"57070_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00000658-200001000-00006","volume":"231","author":"O Bernell","year":"2000","unstructured":"Bernell, O., Lapidus, A. & Hellers, G. Risk factors for surgery and postoperative recurrence in Crohn\u2019s disease [in eng]. Ann Surg 231(1), 38\u201345 (2000).","journal-title":"Ann Surg"},{"issue":"1","key":"57070_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-physiol-021317-121515","volume":"81","author":"S Schneider","year":"2019","unstructured":"Schneider, S., Wright, C. M. & Heuckeroth, R. O. Unexpected roles for the second brain: Enteric nervous system as master regulator of bowel function. Annu. Rev. Physiol. 81(1), 1\u201325 (2019).","journal-title":"Annu. Rev. Physiol."},{"key":"57070_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrgastro.2012.32","volume":"9","author":"JB Furness","year":"2012","unstructured":"Furness, J. B. The enteric nervous system and neurogastroenterology. Nat. Rev. Gastroenterol. Hepatol. 9, 286 (2012).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"57070_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.tips.2007.08.003","volume":"28","author":"R De Giorgio","year":"2007","unstructured":"De Giorgio, R. et al. Novel therapeutic targets for enteric nervous system disorders. Trends Pharmacol. Sci. 28(9), 473\u2013481 (2007).","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"57070_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2982.2004.00607.x","volume":"17","author":"AE Lomax","year":"2005","unstructured":"Lomax, A. E., Fern\u00e1ndez, E. & Sharkey, K. A. Plasticity of the enteric nervous system during intestinal inflammation. Neurogastroenterol. Motil. 17(1), 4\u201315 (2005).","journal-title":"Neurogastroenterol. Motil."},{"key":"57070_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1742-2094-7-37","volume":"7","author":"SE Lakhan","year":"2010","unstructured":"Lakhan, S. E. & Kirchgessner, A. Neuroinflammation in inflammatory bowel disease. J. Neuroinflammation 7, 37 (2010).","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"57070_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1034\/j.1600-0773.2003.930101.x","volume":"93","author":"MB Hansen","year":"2003","unstructured":"Hansen, M. B. The enteric nervous system III: A target for pharmacological treatment. Pharmacol. Toxicol. 93(1), 1\u201313 (2003).","journal-title":"Pharmacol. Toxicol."},{"issue":"8\u20139","key":"57070_CR9","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1023\/A:1012313424144","volume":"26","author":"E Poli","year":"2001","unstructured":"Poli, E. et al. Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis. Neurochem. Res. 26(8\u20139), 1085\u20131093 (2001).","journal-title":"Neurochem. Res."},{"issue":"12","key":"57070_CR10","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1365-2982.2007.00986.x","volume":"19","author":"EM Krauter","year":"2007","unstructured":"Krauter, E. M. et al. Changes in colonic motility and the electrophysiological properties of myenteric neurons persist following recovery from trinitrobenzene sulfonic acid colitis in the guinea pig. Neurogastroenterol. Motil. 19(12), 990\u20131000 (2007).","journal-title":"Neurogastroenterol. Motil."},{"issue":"2","key":"57070_CR11","doi-asserted-by":"publisher","first-page":"G482","DOI":"10.1152\/ajpgi.00355.2006","volume":"292","author":"AE Lomax","year":"2007","unstructured":"Lomax, A. E. et al. Persistent alterations to enteric neural signaling in the guinea pig colon following the resolution of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292(2), G482\u2013G491 (2007).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"8","key":"57070_CR12","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1097\/MIB.0b013e318281f336","volume":"19","author":"A Bressenot","year":"2013","unstructured":"Bressenot, A. et al. Submucosal plexitis as a predictor of postoperative surgical recurrence in Crohn\u2019s disease. Inflamm. Bowel Dis. 19(8), 1654\u20131661 (2013).","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"57070_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1053\/j.gastro.2006.02.025","volume":"130","author":"M Ferrante","year":"2006","unstructured":"Ferrante, M. et al. The value of myenteric plexitis to predict early postoperative Crohn\u2019s disease recurrence. Gastroenterology 130(6), 1595\u20131606 (2006).","journal-title":"Gastroenterology"},{"issue":"9","key":"57070_CR14","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1136\/gut.2009.177782","volume":"58","author":"H Sokol","year":"2009","unstructured":"Sokol, H. et al. Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn\u2019s disease. Gut 58(9), 1218\u20131225 (2009).","journal-title":"Gut"},{"issue":"14","key":"57070_CR15","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.2174\/1389450121666200516173242","volume":"21","author":"R Stavely","year":"2020","unstructured":"Stavely, R., Abalo, R. & Nurgali, K. Targeting enteric neurons and plexitis for the management of inflammatory bowel disease. Curr. Drug Targets 21(14), 1428\u20131439 (2020).","journal-title":"Curr. Drug Targets"},{"key":"57070_CR16","doi-asserted-by":"crossref","unstructured":"Bernardazzi, C,, P\u00eago, B. & de Souza, H. S. P. Neuroimmunomodulation in the gut: Focus on inflammatory bowel disease. Mediators Inflamm. 2016 (2016).","DOI":"10.1155\/2016\/1363818"},{"issue":"9","key":"57070_CR17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.tins.2016.06.007","volume":"39","author":"KG Margolis","year":"2016","unstructured":"Margolis, K. G. & Gershon, M. D. Enteric neuronal regulation of intestinal inflammation. Trends Neurosci. 39(9), 614\u2013624 (2016).","journal-title":"Trends Neurosci."},{"issue":"1","key":"57070_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cgh.2013.06.021","volume":"12","author":"GM Forbes","year":"2014","unstructured":"Forbes, G. M. et al. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn\u2019s disease refractory to biologic therapy. Clin. Gastroenterol. Hepatol. 12(1), 64\u201371 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"57070_CR19","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2147\/JIR.S400447","volume":"16","author":"CM Tian","year":"2023","unstructured":"Tian, C. M. et al. Stem cell therapy in inflammatory bowel disease: A review of achievements and challenges. J. Inflamm. Res. 16, 2089\u20132119 (2023).","journal-title":"J. Inflamm. Res."},{"issue":"9","key":"57070_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/sctm.19-0446","volume":"9","author":"R Stavely","year":"2020","unstructured":"Stavely, R. & Nurgali, K. The emerging antioxidant paradigm of mesenchymal stem cell therapy. Stem Cells Transl. Med. 9(9), 985\u20131006 (2020).","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"57070_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2174\/157488811794480762","volume":"6","author":"I Kassis","year":"2011","unstructured":"Kassis, I., Vaknin-Dembinsky, A. & Karussis, D. Bone marrow mesenchymal stem cells: Agents of immunomodulation and neuroprotection. Curr. Stem Cell Res. Ther. 6(1), 63\u201368 (2011).","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"4","key":"57070_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2492\/inflammregen.34.184","volume":"34","author":"R Stavely","year":"2014","unstructured":"Stavely, R. et al. Mesenchymal stem cells for the treatment of inflammatory bowel disease: From experimental models to clinical application. Inflamm. Regen. 34(4), 184\u2013197 (2014).","journal-title":"Inflamm. Regen."},{"issue":"11","key":"57070_CR23","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.dld.2018.08.015","volume":"50","author":"C Gregoire","year":"2018","unstructured":"Gregoire, C. et al. Allogeneic mesenchymal stromal cells for refractory luminal Crohn\u2019s disease: A phase I-II study. Dig. Liver Dis. 50(11), 1251\u20131255 (2018).","journal-title":"Dig. Liver Dis."},{"issue":"3","key":"57070_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050054","volume":"5","author":"CK Heazlewood","year":"2008","unstructured":"Heazlewood, C. K. et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 5(3), e54 (2008).","journal-title":"PLoS Med."},{"issue":"3","key":"57070_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/mi.2010.74","volume":"4","author":"RD Eri","year":"2011","unstructured":"Eri, R. D. et al. An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity. Mucosal Immunol. 4(3), 354\u2013364 (2011).","journal-title":"Mucosal Immunol."},{"issue":"12","key":"57070_CR26","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3390\/biom12121831","volume":"12","author":"R Stavely","year":"2022","unstructured":"Stavely, R. et al. Oxidative stress-induced HMGB1 translocation in myenteric neurons contributes to neuropathy in colitis. Biomolecules 12(12), 1831 (2022).","journal-title":"Biomolecules"},{"key":"57070_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13287-015-0231-x","volume":"6","author":"R Stavely","year":"2015","unstructured":"Stavely, R. et al. Human adult stem cells derived from adipose tissue and bone marrow attenuate enteric neuropathy in the guinea-pig model of acute colitis. Stem Cell Res. Ther. 6, 244 (2015).","journal-title":"Stem Cell Res. Ther."},{"issue":"9","key":"57070_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139023","volume":"10","author":"AM Robinson","year":"2015","unstructured":"Robinson, A. M. et al. Neuroprotective potential of mesenchymal stem cell-based therapy in acute stages of TNBS-induced colitis in guinea-pigs. PLoS ONE 10(9), e0139023 (2015).","journal-title":"PLoS ONE"},{"issue":"1","key":"57070_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13287-017-0540-3","volume":"8","author":"AM Robinson","year":"2017","unstructured":"Robinson, A. M. et al. The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis. Stem Cell Res. Ther. 8(1), 87 (2017).","journal-title":"Stem Cell Res. Ther."},{"issue":"11","key":"57070_CR30","doi-asserted-by":"publisher","first-page":"G1115","DOI":"10.1152\/ajpgi.00174.2014","volume":"307","author":"AM Robinson","year":"2014","unstructured":"Robinson, A. M. et al. Mesenchymal stem cells and conditioned medium avert enteric neuropathy and colon dysfunction in guinea pig TNBS-induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 307(11), G1115\u2013G1129 (2014).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"57070_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13287-015-0254-3","volume":"6","author":"R Stavely","year":"2015","unstructured":"Stavely, R. et al. Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis. Stem Cell Res. Ther. 6, 263 (2015).","journal-title":"Stem Cell Res. Ther."},{"key":"57070_CR32","doi-asserted-by":"publisher","first-page":"30696","DOI":"10.1038\/srep30696","volume":"6","author":"M Wang","year":"2016","unstructured":"Wang, M. et al. Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis. Sci. Rep. 6, 30696 (2016).","journal-title":"Sci. Rep."},{"key":"57070_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13287-015-0166-2","volume":"6","author":"D Forte","year":"2015","unstructured":"Forte, D. et al. Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn\u2019s disease patients in a mouse model of colitis. Stem Cell Res. Ther. 6, 170 (2015).","journal-title":"Stem Cell Res. Ther."},{"issue":"3","key":"57070_CR34","first-page":"79","volume":"1","author":"DB Cury","year":"2016","unstructured":"Cury, D. B. et al. Comparative study of intravenous and topical administration of mesenchymal stem cells in experimental colitis. J. Transl. Sci. 1(3), 79\u201382 (2016).","journal-title":"J. Transl. Sci."},{"issue":"6","key":"57070_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/ecco-jcc\/jjv050","volume":"9","author":"K Holgersen","year":"2015","unstructured":"Holgersen, K. et al. High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis. J. Crohn\u2019s Colitis 9(6), 492\u2013506 (2015).","journal-title":"J. Crohn's Colitis"},{"issue":"6","key":"57070_CR36","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.cell.2020.08.003","volume":"182","author":"E Drokhlyansky","year":"2020","unstructured":"Drokhlyansky, E. et al. The human and mouse enteric nervous system at single-cell resolution. Cell 182(6), 1606-1622.e1623 (2020).","journal-title":"Cell"},{"issue":"4","key":"57070_CR37","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/codi.12896","volume":"17","author":"H Misteli","year":"2015","unstructured":"Misteli, H. et al. Myenteric plexitis at the proximal resection margin is a predictive marker for surgical recurrence of ileocaecal Crohn\u2019s disease. Colorectal Dis. 17(4), 304\u2013310 (2015).","journal-title":"Colorectal Dis."},{"issue":"2","key":"57070_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.23922\/jarc.2016-006","volume":"1","author":"S Nakao","year":"2017","unstructured":"Nakao, S. et al. Predictive value of myenteric and submucosal plexitis for postoperative Crohn\u2019s disease recurrence. J. Anus Rectum Colon 1(2), 56\u201364 (2017).","journal-title":"J. Anus Rectum Colon"},{"issue":"1","key":"57070_CR39","doi-asserted-by":"publisher","first-page":"G39","DOI":"10.1152\/ajpgi.00165.2017","volume":"314","author":"IAM Brown","year":"2018","unstructured":"Brown, I. A. M. & Gulbransen, B. D. The antioxidant glutathione protects against enteric neuron death in situ, but its depletion is protective during colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 314(1), G39-g52 (2018).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"11","key":"57070_CR40","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/ars.2016.6748","volume":"26","author":"D Klein","year":"2017","unstructured":"Klein, D. et al. Mesenchymal stem cell therapy protects lungs from radiation-induced endothelial cell loss by restoring superoxide dismutase 1 expression. Antioxid. Redox Signal. 26(11), 563\u2013582 (2017).","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"57070_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1742-2094-11-106","volume":"11","author":"Q Sun","year":"2014","unstructured":"Sun, Q. et al. Early release of high-mobility group box 1 (HMGB1) from neurons in experimental subarachnoid hemorrhage in vivo and in vitro. J. Neuroinflammation 11(1), 106 (2014).","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"57070_CR42","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1089\/ars.2013.5179","volume":"20","author":"C Janko","year":"2014","unstructured":"Janko, C. et al. Redox modulation of HMGB1-related signaling. Antioxid. Redox Signal. 20(7), 1075\u20131085 (2014).","journal-title":"Antioxid. Redox Signal."},{"issue":"23","key":"57070_CR43","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.lfs.2008.09.016","volume":"83","author":"F Tanaka","year":"2008","unstructured":"Tanaka, F. et al. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci. 83(23), 771\u2013779 (2008).","journal-title":"Life Sci."},{"issue":"6","key":"57070_CR44","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3892\/ijmm.2013.1529","volume":"32","author":"D Zuo","year":"2013","unstructured":"Zuo, D. et al. Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory T cells for the treatment of experimental colitis. Int. J. Mol. Med. 32(6), 1337\u20131344 (2013).","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"57070_CR45","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/gut.2008.168534","volume":"58","author":"E Gonzalez-Rey","year":"2009","unstructured":"Gonzalez-Rey, E. et al. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58(7), 929\u2013939 (2009).","journal-title":"Gut"},{"issue":"1","key":"57070_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10620-016-4166-6","volume":"62","author":"M Xie","year":"2017","unstructured":"Xie, M. et al. Comparison of adipose-derived and bone marrow mesenchymal stromal cells in a murine model of Crohn\u2019s disease. Dig. Dis. Sci. 62(1), 115\u2013123 (2017).","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"57070_CR47","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ibd.20382","volume":"14","author":"Y Ando","year":"2008","unstructured":"Ando, Y. et al. Subcutaneous adipose tissue\u2013derived stem cells facilitate colonic mucosal recovery from 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)\u2013induced colitis in rats. Inflamm. Bowel Dis. 14(6), 826\u2013838 (2008).","journal-title":"Inflamm. Bowel Dis."},{"issue":"9","key":"57070_CR48","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3727\/096368910X557245","volume":"20","author":"L Liang","year":"2011","unstructured":"Liang, L. et al. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis. Cell Transplant. 20(9), 1395\u20131408 (2011).","journal-title":"Cell Transplant."},{"issue":"12","key":"57070_CR49","doi-asserted-by":"publisher","first-page":"7787","DOI":"10.4049\/jimmunol.0902318","volume":"183","author":"Q Zhang","year":"2009","unstructured":"Zhang, Q. et al. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J. Immunol. 183(12), 7787\u20137798 (2009).","journal-title":"J. Immunol."},{"issue":"3","key":"57070_CR50","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","volume":"136","author":"MA Gonz\u00e1lez","year":"2009","unstructured":"Gonz\u00e1lez, M. A. et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136(3), 978\u2013989 (2009).","journal-title":"Gastroenterology"},{"issue":"8","key":"57070_CR51","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s10620-017-4578-y","volume":"62","author":"H Takeyama","year":"2017","unstructured":"Takeyama, H. et al. Adipose-derived stem cells ameliorate experimental murine colitis via TSP-1-dependent activation of latent TGF-\u03b2. Dig. Dis. Sci. 62(8), 1963\u20131974 (2017).","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"57070_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.autneu.2004.10.006","volume":"117","author":"L Boyer","year":"2005","unstructured":"Boyer, L. et al. Myenteric plexus injury and apoptosis in experimental colitis. Auton. Neurosci. 117(1), 41\u201353 (2005).","journal-title":"Auton. Neurosci."},{"issue":"6","key":"57070_CR53","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/gutjnl-2013-304676","volume":"63","author":"G Matteoli","year":"2014","unstructured":"Matteoli, G. et al. A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. Gut 63(6), 938\u2013948 (2014).","journal-title":"Gut"},{"key":"57070_CR54","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/gut.2010.227546","volume":"60","author":"Y Tsuchida","year":"2011","unstructured":"Tsuchida, Y. et al. Neuronal stimulation with 5-hydroxytryptamine 4 receptor induces anti-inflammatory actions via \u03b17nACh receptors on muscularis macrophages associated with postoperative ileus. Gut 60, 638\u2013647 (2011).","journal-title":"Gut"},{"key":"57070_CR55","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ncpgasthep0316","volume":"2","author":"GAO Thomas","year":"2005","unstructured":"Thomas, G. A. O., Rhodes, J. & Ingram, J. R. Mechanisms of disease: Nicotine\u2014A review of its actions in the context of gastrointestinal disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 536\u2013544 (2005).","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"57070_CR56","first-page":"4722","volume":"4","author":"J McGrath","year":"2004","unstructured":"McGrath, J., McDonald, J. W. & Macdonald, J. K. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst. Rev. 4, 4722 (2004).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"57070_CR57","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1582-4934.2011.01298.x","volume":"16","author":"N Bernardini","year":"2012","unstructured":"Bernardini, N. et al. Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis. J. Cell Mol. Med. 16(2), 318\u2013327 (2012).","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"57070_CR58","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1365-2982.2009.01329.x","volume":"21","author":"K Nurgali","year":"2009","unstructured":"Nurgali, K. Plasticity and ambiguity of the electrophysiological phenotypes of enteric neurons. Neurogastroenterol. Motil. 21(9), 903\u2013913 (2009).","journal-title":"Neurogastroenterol. Motil."},{"issue":"2","key":"57070_CR59","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1113\/jphysiol.2007.135947","volume":"583","author":"K Nurgali","year":"2007","unstructured":"Nurgali, K. et al. Phenotypic changes of morphologically identified guinea-pig myenteric neurons following intestinal inflammation. J. Physiol. 583(2), 593\u2013609 (2007).","journal-title":"J. Physiol."},{"issue":"3","key":"57070_CR60","doi-asserted-by":"publisher","first-page":"G582","DOI":"10.1152\/ajpgi.00026.2009","volume":"297","author":"K Nurgali","year":"2009","unstructured":"Nurgali, K. et al. Slow synaptic transmission in myenteric AH neurons from the inflamed guinea pig ileum. Am. J. Physiol. Gastrointest. Liver Physiol. 297(3), G582\u2013G593 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"57070_CR61","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1113\/jphysiol.2010.197707","volume":"589","author":"K Nurgali","year":"2011","unstructured":"Nurgali, K. et al. Morphological and functional changes in guinea-pig neurons projecting to the ileal mucosa at early stages after inflammatory damage. J. Physiol. 589(2), 325\u2013339 (2011).","journal-title":"J. Physiol."},{"issue":"6","key":"57070_CR62","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1159\/000198039","volume":"15","author":"M Oehmichen","year":"1977","unstructured":"Oehmichen, M. & Reifferscheid, P. Intramural ganglion cell degeneration in inflammatory bowel disease. Digestion 15(6), 482\u2013496 (1977).","journal-title":"Digestion"},{"key":"57070_CR63","first-page":"111","volume":"71","author":"J Riemann","year":"1982","unstructured":"Riemann, J. & Schmidt, H. Ultrastructural changes in the gut autonomic nervous system following laxative abuse and in other conditions. Scand. J. Gastroenterol. Suppl. 71, 111\u2013124 (1982).","journal-title":"Scand. J. Gastroenterol. Suppl."},{"issue":"5","key":"57070_CR64","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.jcmgh.2021.07.003","volume":"12","author":"D Dora","year":"2021","unstructured":"Dora, D. et al. Evidence of a myenteric plexus barrier and its macrophage-dependent degradation during murine colitis: Implications in enteric neuroinflammation. Cell. Mole. Gastroenterol. Hepatol. 12(5), 1617\u20131641 (2021).","journal-title":"Cell. Mole. Gastroenterol. Hepatol."},{"issue":"7","key":"57070_CR65","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00210-014-0985-1","volume":"387","author":"A Piechota-Polanczyk","year":"2014","unstructured":"Piechota-Polanczyk, A. & Fichna, J. Review article: The role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 387(7), 605\u2013620 (2014).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"issue":"10","key":"57070_CR66","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1007\/BF02093613","volume":"41","author":"L Lih-Brody","year":"1996","unstructured":"Lih-Brody, L. et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig. Dis. Sci. 41(10), 2078\u20132086 (1996).","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"57070_CR67","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2982.2010.01611.x","volume":"23","author":"B Chandrasekharan","year":"2011","unstructured":"Chandrasekharan, B. et al. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol. Motil. Off. J. Eur. Gastrointest. Motil. Soc. 23(2), 131-138.e126 (2011).","journal-title":"Neurogastroenterol. Motil. Off. J. Eur. Gastrointest. Motil. Soc."},{"issue":"4","key":"57070_CR68","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/bph.14114","volume":"175","author":"RM McQuade","year":"2018","unstructured":"McQuade, R. M. et al. Oxaliplatin-induced enteric neuronal loss and intestinal dysfunction is prevented by co-treatment with BGP-15. Br. J. Pharmacol. 175(4), 656\u2013677 (2018).","journal-title":"Br. J. Pharmacol."},{"issue":"24","key":"57070_CR69","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1111\/bph.13646","volume":"173","author":"RM McQuade","year":"2016","unstructured":"McQuade, R. M. et al. Role of oxidative stress in oxaliplatin-induced enteric neuropathy and colonic dysmotility in mice. Br. J. Pharmacol. 173(24), 3502\u20133521 (2016).","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"57070_CR70","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1474-9726.2006.00214.x","volume":"5","author":"C Thrasivoulou","year":"2006","unstructured":"Thrasivoulou, C. et al. Reactive oxygen species, dietary restriction and neurotrophic factors in age-related loss of myenteric neurons. Aging Cell 5(3), 247\u2013257 (2006).","journal-title":"Aging Cell"},{"issue":"12","key":"57070_CR71","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1089\/scd.2010.0093","volume":"19","author":"A Valle-Prieto","year":"2010","unstructured":"Valle-Prieto, A. & Conget, P. A. Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev. 19(12), 1885\u20131893 (2010).","journal-title":"Stem Cells Dev."},{"issue":"10","key":"57070_CR72","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/sctm.18-0045","volume":"7","author":"J Redondo","year":"2018","unstructured":"Redondo, J. et al. Dysregulation of mesenchymal stromal cell antioxidant responses in progressive multiple sclerosis. Stem Cells Transl. Med. 7(10), 748\u2013758 (2018).","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"57070_CR73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jcyt.2017.08.007","volume":"20","author":"P Sarkar","year":"2018","unstructured":"Sarkar, P. et al. Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis. Cytotherapy 20(1), 21\u201328 (2018).","journal-title":"Cytotherapy"},{"issue":"3","key":"57070_CR74","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pharmthera.2013.11.001","volume":"141","author":"D Musumeci","year":"2014","unstructured":"Musumeci, D., Roviello, G. N. & Montesarchio, D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol. Ther. 141(3), 347\u2013357 (2014).","journal-title":"Pharmacol. Ther."},{"key":"57070_CR75","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00011-019-01251-x","volume":"68","author":"L Huang","year":"2019","unstructured":"Huang, L. et al. High-mobility group box-1 inhibition stabilizes intestinal permeability through tight junctions in experimental acute necrotizing pancreatitis. Inflamm. Res. 68, 677\u2013689 (2019).","journal-title":"Inflamm. Res."},{"key":"57070_CR76","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.intimp.2018.01.002","volume":"56","author":"X Cheng","year":"2018","unstructured":"Cheng, X. et al. Kaempferol alleviates LPS-induced neuroinflammation and BBB dysfunction in mice via inhibiting HMGB1 release and down-regulating TLR4\/MyD88 pathway. Int. Immunopharmacol. 56, 29\u201335 (2018).","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"57070_CR77","first-page":"e3410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 18(7), e3410 (2020).","journal-title":"PLoS Biol."},{"issue":"4","key":"57070_CR78","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4), 315\u2013317 (2006).","journal-title":"Cytotherapy"},{"issue":"1","key":"57070_CR79","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00441-022-03633-w","volume":"389","author":"AM Robinson","year":"2022","unstructured":"Robinson, A. M. et al. Mesenchymal stem cell treatment for enteric neuropathy in the Winnie mouse model of spontaneous chronic colitis. Cell Tissue Res. 389(1), 41\u201370 (2022).","journal-title":"Cell Tissue Res."},{"issue":"5","key":"57070_CR80","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/ibd\/izy016","volume":"24","author":"R Stavely","year":"2018","unstructured":"Stavely, R. et al. The onset and progression of chronic colitis parallels increased mucosal serotonin release via enterochromaffin cell hyperplasia and downregulation of the serotonin reuptake transporter. Inflamm. Bowel Dis. 24(5), 1021\u20131034 (2018).","journal-title":"Inflamm. Bowel Dis."},{"issue":"8","key":"57070_CR81","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/ibd\/izac060","volume":"28","author":"R Stavely","year":"2022","unstructured":"Stavely, R. et al. Divergent adaptations in autonomic nerve activity and neuroimmune signaling associated with the severity of inflammation in chronic colitis. Inflamm. Bowel Dis. 28(8), 1229\u20131243 (2022).","journal-title":"Inflamm. Bowel Dis."},{"issue":"7","key":"57070_CR82","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH image to ImageJ: 25 years of image analysis. Nat. Methods 9(7), 671 (2012).","journal-title":"Nat. Methods"},{"issue":"1","key":"57070_CR83","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden, C. T. et al. Image J2: ImageJ for the next generation of scientific image data. BMC Bioinform. 18(1), 529 (2017).","journal-title":"BMC Bioinform."},{"issue":"3","key":"57070_CR84","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00441-015-2251-3","volume":"362","author":"AA Rahman","year":"2015","unstructured":"Rahman, A. A. et al. Alterations in the distal colon innervation in Winnie mouse model of spontaneous chronic colitis. Cell Tissue Res. 362(3), 497\u2013512 (2015).","journal-title":"Cell Tissue Res."},{"issue":"1","key":"57070_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29(1), 15\u201321 (2013).","journal-title":"Bioinformatics"},{"issue":"16","key":"57070_CR86","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25(16), 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"issue":"7","key":"57070_CR87","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30(7), 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"issue":"646","key":"57070_CR88","doi-asserted-by":"publisher","first-page":"eabl8753","DOI":"10.1126\/scitranslmed.abl8753","volume":"14","author":"R Stavely","year":"2022","unstructured":"Stavely, R. et al. Schwann cells in the subcutaneous adipose tissue have neurogenic potential and can be used for regenerative therapies. Sci. Transl. Med. 14(646), eabl8753 (2022).","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"57070_CR89","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/ng.3947","volume":"49","author":"LA Peters","year":"2017","unstructured":"Peters, L. A. et al. A functional genomics predictive network model identifies regulators of inflammatory bowel disease. Nat. Genet. 49(10), 1437\u20131449 (2017).","journal-title":"Nat. Genet."},{"issue":"9","key":"57070_CR90","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/stem.3388","volume":"39","author":"R Stavely","year":"2021","unstructured":"Stavely, R. et al. Enteric mesenchymal cells support the growth of postnatal enteric neural stem cells. Stem Cells 39(9), 1236\u20131252 (2021).","journal-title":"Stem Cells"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57070-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57070-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57070-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T05:09:45Z","timestamp":1710911385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57070-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["57070"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-57070-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"9 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6649"}}